PetSmart Voluntarily Recalls Dentley's Beef Hooves

PetSmart (NASDAQ: PETM) is voluntarily recalling two Dentley's Beef Hoof products for potential salmonella contamination. The products were manufactured by Pet Carousel, Inc. in Sanger, Calif.

The recalled products include only the following types of Dentley's Beef Hooves purchased between Oct. 2, 2009 and Nov. 3, 2009:

Dentley's Bulk Cattle Hoof UPC# 73725703323
Dentley's 10 Pack Beef Hooves UPC# 73725736055

No other products are included in this recall.

The affected products were shipped from the Pet Carousel plant to three PetSmart distribution centers in Ottawa, Ill.; Groveport, Ohio and Newnan, Ga.; and then shipped directly to certain PetSmart stores. Although the affected product was not shipped to every store, as a precautionary measure PetSmart immediately recalled the product from all of its US stores and instituted a register block to prevent any product from being inadvertently scanned and sold. In addition, PetSmart removed the product from the PetSmart.com Web site and notified PetPerks customers with valid e-mail addresses in the PetSmart database who purchased the affected products.

Salmonellosis is an infection with bacteria called salmonella. Most persons infected with salmonella develop diarrhea, fever, and abdominal cramps 12 to 72 hours after infection. The illness usually lasts four to seven days, and most persons recover without treatment. However, in some individuals, the diarrhea may be so severe that the patient needs to be hospitalized. In these patients, the salmonella infection may spread from the intestines to the blood stream, and then to other body sites and can cause death unless the person is treated promptly with antibiotics. The elderly, infants, and those with impaired immune systems are more likely to have a severe illness.

Many dogs do not show clinical signs of salmonella. However, when they do, they often have diarrhea or other signs of systemic infections.

Customers who purchased the recalled products should discontinue use immediately and return the product to any PetSmart store for a complete refund or exchange. Customers who have concerns about their health or their pet's health should consult a medical professional. For additional information about the recall, customers can visit www.petsmartfacts.com, www.petsmart.com ; www.fda.govor contact PetSmart Customer Service at 1-888-839-9638.

-----
www.fayettefrontpage.com
Fayette Front Page
www.georgiafrontpage.com
Georgia Front Page

Actavis Totowa Announces Voluntary Recall at the Retail Level of All Drug Products Manufactured at its Little Falls, New Jersey Facility

Actavis Totowa LLC, a generic drug manufacturer, is announcing a voluntary recall, to the retail level, of all drug products manufactured at its Little Falls, New Jersey facility. This is a precautionary, voluntary action by Actavis following an inspection conducted by the Food and Drug Administration earlier this year.

The inspection at Little Falls revealed operations which did not meet the FDA's or Actavis' standards for good manufacturing practices. Actavis Totowa is voluntarily recalling these products from the pharmacy/retail level, which includes wholesalers and hospitals. The company has informed the FDA regarding this action.

This action is not prompted by product complaints or health hazards associated with the products, which are all prescription medications. Patients who may have these medicines in their possession should continue to take them in accordance with their prescriptions, as the risk of suddenly stopping needed medication may place patients at risk. If patients should wish to obtain replacement medications and/or prescription, they should contact their health care professional or pharmacist. For more information regarding this market action, please visit www.actavis.us/RecallFAQ.

Recall letters have been issued to wholesalers and retailers, instructing them to return product to Capital Returns, Milwaukee, WI.

Actavis Totowa, LLC is a United States subsidiary of Actavis Group hf. This voluntary action is limited only to the Actavis Totowa products manufactured in the Little Falls, NJ facility listed below. Products manufactured by Actavis Elizabeth LLC, Actavis South Atlantic LLC, Actavis Mid Atlantic LLC or Actavis products manufactured in other facilities are thus not impacted by this recall

Amantadine 100mg capsules	Meperidine & Promethazine capsules
Amibid DM ER tablets	Meperidine HCl 100 mg and 50 mg tablets
Amibid DM tablets	Methenamine Mandelate 0.5 g and 1.0 g tablets
Amidrine capsules	Mirtazapine 15 mg, 30 mg, and 45 mg tablets
Amigesic 500 mg caplets and 750 mg caplets	Mirtazapine OD tablets, 15 mg, 30 mg and 45 mg
Amitex PSE tablets	Multi-ret Folic 500 mg tablets
Bellamine S tablets	Multi-vita-bets 0.5 mg and 1.0 mg FL & FE tablets
Betaxolol 10 mg and 20 mg tablets USP	Multi-vita-bets 0.25 mg, 0.5 mg and 1 mg FL tablets
Buspirone HCL 5 mg, 10 mg, 15 mg and 30mg tablets	Naltrexone 50mg tablets
Carisoprodol & Aspirin tablets	Oxycodone & Acetaminophen 5/500mg capsules
Carisoprodol, Aspirin & Codeine tablets	Oxycodone HCl 5 mg, 15 mg and 30 mg tablets
Carisoprodol 350mg tablets	Oxycodone HCl 5 mg capsules
Chlordiazepoxide w/ Clidinium Bromide capsules	Pentazocine & Acetaminophen tablets
Chlorzoxazone 250mg	Pentazocine & Naloxone tablets
Cilostazol tablets 100mg	Phenazopyridine HCl 100 mg and 200 mg tablets
Choline Magnesium Trisalicylate 500 mg, 750 mg and 1000 mg tablets	Phendimetrazine Tartrate 35mg tablets
Cyclobenzaprine HCL 5 mg and 10 mg	Phentermine HCl 37.5 mg tablets
Dexchlorpheniramine Maleate 4 mg and 6 mg tablets	Phentermine HCl 15 mg, 30 mg and 37.5 mg capsules
Dipyridamole 25 mg, 50mg, and 75 mg tablets	Prenatal Formula 3 tablets
Glyburide 1.5 mg, 3.0 mg and 6.0 mg tablets	Prenatal Plus 27 mg FE tablets
Guaifenesin & Codeine Phosphate tablets	Prenatal Rx tablets
Guaifenesin & Phenylephrine tablets	Quinaretic 10mg/12.5mg, 20 mg/12.5 mg and 20 mg/25 mg tablets
Guanfacine 1.0 mg and 2.0 mg HCl tablets	Rifampin 300mg capsules
Hydrocodone & Homatropine tablets	Sodium FL 0.5 mg and 1.0 mg tablets
Hydromorphone HCl tablets	Tizanidine HCl 2 mg and 4 mg tablets
Hydroxyzine 10 mg, 25 mg and 50 mg tablets	Trimethobenzamide 300mg capsules
Hyoscyamine Sulfate 0.125 mg SL	Trimipramine Maleate 25mg, 50mg, 100mg capsules
Hyoscyamine Sulfate 0.375mg SR tablets	Trivita 1 mg FL tablets
Hyoscyamine Sulfate 0.125 mg (oral) tablets	Ursodiol capsules, 300mg
Isradipine 2.5 mg and 5 mg capsules	Vitacon Forte capsules
Loxapine 5 mg, 10 mg, 25 mg, and 50 mg capsules	Vitaplex Plus tablets
Meclizine Chewable 25 mg tablets	Vitaplex tablets (FC)
Meloxicam 7.5 mg and 15 mg tablets	Yohimbine HCl 5.4 mg tablets

Answers to frequently asked questions regarding this market action can be found on www.actavis.us/RecallFAQ.